{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:53:35Z","timestamp":1777092815600,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-026-04286-x","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:32:26Z","timestamp":1777091546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional outcomes after reperfusion therapy for acute ischemic stroke: Is there a modifying effect of renin\u2013angiotensin\u2013aldosterone system inhibition?"],"prefix":"10.1007","volume":"49","author":[{"given":"Sophie","family":"Samuel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandi","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritvij","family":"Bowry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"4286_CR1","doi-asserted-by":"publisher","first-page":"E344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 50:E344\u2013E418","journal-title":"Stroke"},{"key":"4286_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-0040-1709153","volume":"37","author":"JM Ospel","year":"2020","unstructured":"Ospel JM, McTaggart R, Kashani N, Psychogios M, Almekhlafi M, Goyal M (2020) Evolution of stroke thrombectomy techniques to optimize first-pass complete reperfusion. Semin Intervent Radiol 37:119\u2013131","journal-title":"Semin Intervent Radiol"},{"key":"4286_CR3","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M, Menon BK, Van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387:1723\u20131731","journal-title":"Lancet"},{"key":"4286_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1706442","volume":"378","author":"RG Nogueira","year":"2018","unstructured":"Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P et al (2018) Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 378:11\u201321","journal-title":"N Engl J Med"},{"key":"4286_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2018-014569","volume":"15","author":"G Turc","year":"2023","unstructured":"Turc G, Bhogal P, Fischer U, Khatri P, Lobotesis K, Mazighi M et al (2023) European stroke organisation (ESO) - European society for minimally invasive neurological therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke. J Neurointerv Surg 15:e8","journal-title":"J Neurointerv Surg"},{"key":"4286_CR6","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD et al (2018) 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology\/American Heart Association task force on clinical practice guidelines. Hypertension 71:1269\u20131324","journal-title":"Hypertension"},{"key":"4286_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2023.1137197","author":"HW Lee","year":"2023","unstructured":"Lee HW, Kim S, Jo Y, Kim Y, Ye BS, Yu YM (2023) Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer\u2019s disease: a nationwide population-based cohort study. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/FNAGI.2023.1137197","journal-title":"Front Aging Neurosci"},{"key":"4286_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/S10072-008-0963-9","author":"S Marcheselli","year":"2008","unstructured":"Marcheselli S, Micieli G (2008) Renin-angiotensin system and stroke. Neurol Sci. https:\/\/doi.org\/10.1007\/S10072-008-0963-9","journal-title":"Neurol Sci"},{"key":"4286_CR9","doi-asserted-by":"publisher","unstructured":"De Silva TM, Faraci FM (2013) Effects of angiotensin II on the cerebral circulation: role of oxidative stress. Front Physiol. https:\/\/doi.org\/10.3389\/FPHYS.2012.00484","DOI":"10.3389\/FPHYS.2012.00484"},{"key":"4286_CR10","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/01.STR.0000163084.16505.e3","volume":"36","author":"S Kim-Mitsuyama","year":"2005","unstructured":"Kim-Mitsuyama S, Yamamoto E, Tanaka T, Zhan Y, Izumi Y, Izumiya Y et al (2005) Critical role of angiotensin II in excess salt-induced brain oxidative stress of stroke-prone spontaneously hypertensive rats. Stroke 36:1077\u20131082","journal-title":"Stroke"},{"key":"4286_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS23073876","author":"S Andone","year":"2022","unstructured":"Andone S, Bajko Z, Motataianu A, Maier S, Barcutean L, Balasa R (2022) Neuroprotection in stroke\u2014focus on the renin-angiotensin system: a systematic review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS23073876","journal-title":"Int J Mol Sci"},{"key":"4286_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ajh\/hpae033","volume":"37","author":"S Samuel","year":"2024","unstructured":"Samuel S, Craver K, Miller C, Pelsue B, Gonzalez C, Allison TA et al (2024) Reviving decades-old wisdom: longitudinal analysis of renin-angiotensin system inhibitors and its effects on acute ischemic stroke to improve outcomes. Am J Hypertens 37:531\u2013539","journal-title":"Am J Hypertens"},{"key":"4286_CR13","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","volume":"358","author":"S MacMahon","year":"2001","unstructured":"MacMahon S, Neal B, Tzourio C, Rodgers A, Woodward M, Cutler J et al (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358:1033\u20131041","journal-title":"Lancet"},{"key":"4286_CR14","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1586\/14737175.7.9.1085","volume":"7","author":"HC Diener","year":"2007","unstructured":"Diener HC (2007) The PRoFESS trial: future impact on secondary stroke prevention. Expert Rev Neurother 7:1085\u20131091","journal-title":"Expert Rev Neurother"},{"key":"4286_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"BB Love","year":"1993","unstructured":"Love BB, Bendixen BH (1993) Classification of subtype of acute ischemic stroke definitions for use in a multicenter clinical trial. Stroke 24:35\u201341","journal-title":"Stroke"},{"key":"4286_CR16","doi-asserted-by":"publisher","first-page":"E319","DOI":"10.1542\/hpeds.2023-007259","volume":"13","author":"J Cotter","year":"2023","unstructured":"Cotter J, Schmiege S, Moss A, Ambroggio L (2023) How to interact with interactions: what clinicians should know about statistical interactions. Hosp Pediatr 13:E319\u2013E323","journal-title":"Hosp Pediatr"},{"key":"4286_CR17","doi-asserted-by":"publisher","unstructured":"Cleophas TJ, Zwinderman AH, Cleophas TF (2006) Interaction effects in clinical trials. In: Statistics applied to clinical trials. Springer, Dordrecht. https:\/\/doi.org\/10.1007\/978-1-4020-4650-6_17","DOI":"10.1007\/978-1-4020-4650-6_17"},{"key":"4286_CR18","doi-asserted-by":"crossref","unstructured":"(1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581\u20131588","DOI":"10.1056\/NEJM199512143332401"},{"key":"4286_CR19","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E, Brozman M, D\u00e1valos A, Guidetti D et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317\u20131329","journal-title":"N Engl J Med"},{"key":"4286_CR20","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1056\/NEJMoa2103879","volume":"385","author":"JC Grotta","year":"2021","unstructured":"Grotta JC, Yamal J-M, Parker SA, Rajan SS, Gonzales NR, Jones WJ et al (2021) Prospective, multicenter, controlled trial of mobile stroke units. N Engl J Med 385:971\u2013981","journal-title":"N Engl J Med"},{"key":"4286_CR21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","volume":"372","author":"BCV Campbell","year":"2015","unstructured":"Campbell BCV, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N et al (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372:1009\u20131018","journal-title":"N Engl J Med"},{"key":"4286_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-343","author":"PSS Fransen","year":"2014","unstructured":"Fransen PSS, Beumer D, Berkhemer OA, van den Berg LA, Lingsma H, van der Lugt A et al (2014) MR clean, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials. https:\/\/doi.org\/10.1186\/1745-6215-15-343","journal-title":"Trials"},{"key":"4286_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11886-006-0034-x","volume":"8","author":"TE Meyer","year":"2006","unstructured":"Meyer TE (2006) The ESCAPE trial. Curr Cardiol Rep 8:201\u2013203","journal-title":"Curr Cardiol Rep"},{"key":"4286_CR24","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1148\/radiol.2016160204","volume":"279","author":"M Goyal","year":"2016","unstructured":"Goyal M, Jadhav AP, Bonafe A, Diener H, Pereira VM, Levy E et al (2016) Analysis of workflow and time to treatment and the effects on outcome in endovascular treatment of acute ischemic stroke: results from the SWIFT PRIME randomized controlled trial. Radiology 279:888\u2013897","journal-title":"Radiology"},{"key":"4286_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3174\/ajnr.A5463","volume":"39","author":"FS Al-Ajlan","year":"2018","unstructured":"Al-Ajlan FS, Sultan ASA, Minhas P, Assis Z, Miquel MAD, Millan M et al (2018) Posttreatment infarct volumes when compared with 24-hour and 90-day clinical outcomes: Insights from the REVASCAT randomized controlled trial. Am J Neuroradiol 39:107\u2013110","journal-title":"Am J Neuroradiol"},{"key":"4286_CR26","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMoa2001123","volume":"382","author":"P Yang","year":"2020","unstructured":"Yang P, Zhang Y, Zhang L, Zhang Y, Treurniet KM, Chen W et al (2020) Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med 382:1981\u20131993","journal-title":"N Engl J Med"},{"key":"4286_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1001\/jama.2020.23523","volume":"325","author":"W Zi","year":"2021","unstructured":"Zi W, Qiu Z, Li F, Sang H, Wu D, Luo W et al (2021) Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial. JAMA 325:234","journal-title":"JAMA"},{"key":"4286_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1001\/jama.2020.23522","volume":"325","author":"K Suzuki","year":"2021","unstructured":"Suzuki K, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, Takayama Y et al (2021) Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke: The SKIP randomized clinical trial. JAMA 325:244\u2013253","journal-title":"JAMA"},{"key":"4286_CR29","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/S0895-7061(01)02273-7","volume":"15","author":"DE Vaughan","year":"2002","unstructured":"Vaughan DE (2002) Angiotensin and vascular fibrinolytic balance. Am J Hypertens 15:3S-8S","journal-title":"Am J Hypertens"},{"key":"4286_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/sj.ki.5002268","volume":"72","author":"NJ Brown","year":"2007","unstructured":"Brown NJ, Bradford J, Wang Z, Lea W, Ma L, Ma J et al (2007) Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency. Kidney Int 72:72\u201381","journal-title":"Kidney Int"},{"key":"4286_CR31","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1182\/blood-2011-07-369512","volume":"119","author":"B Niego","year":"2012","unstructured":"Niego B, Freeman R, Puschmann TB, Turnley AM, Medcalf RL (2012) T-PA\u2013specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes. Blood 119:4752\u20134761","journal-title":"Blood"},{"key":"4286_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/ajh\/hpu197","volume":"28","author":"S Villapol","year":"2015","unstructured":"Villapol S, Saavedra JM (2015) Neuroprotective effects of angiotensin receptor blockers. Am J Hypertens 28:289\u2013299","journal-title":"Am J Hypertens"},{"key":"4286_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.nbd.2017.08.011","volume":"108","author":"Q Li","year":"2017","unstructured":"Li Q, Han X, Lan X, Hong X, Li Q, Gao Y et al (2017) Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia. Neurobiol Dis 108:173\u2013182","journal-title":"Neurobiol Dis"},{"key":"4286_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1613464","volume":"16","author":"M Yang","year":"2025","unstructured":"Yang M, Liu B, Chen B, Shen Y, Liu G (2025) Cerebral ischemia-reperfusion injury: mechanisms and promising therapies. Front Pharmacol 16:1613464","journal-title":"Front Pharmacol"},{"key":"4286_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12030501","volume":"12","author":"C Briones-Valdivieso","year":"2024","unstructured":"Briones-Valdivieso C, Briones F, Orellana-Urz\u00faa S, Chichiarelli S, Saso L, Rodrigo R (2024) Novel multi-antioxidant approach for ischemic stroke therapy targeting the role of oxidative stress. Biomedicines 12:501","journal-title":"Biomedicines"},{"key":"4286_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/nep3.45","volume":"2","author":"S Huang","year":"2024","unstructured":"Huang S, Zhang M (2024) The role of angiotensin II type 1 receptor pathway in cerebral ischemia-reperfusion injury: implications for the neuroprotective effect of ARBs. Neuroprotection 2:100\u2013119","journal-title":"Neuroprotection"},{"key":"4286_CR37","doi-asserted-by":"publisher","first-page":"10805","DOI":"10.1007\/s12035-024-04237-x","volume":"61","author":"M Ali","year":"2024","unstructured":"Ali M, Tabassum H, Alam MM, Alothaim AS, Al-Malki ES, Jamal A et al (2024) Valsartan: an angiotensin receptor blocker modulates BDNF expression and provides neuroprotection against cerebral ischemic reperfusion injury. Mol Neurobiol 61:10805\u201310819","journal-title":"Mol Neurobiol"},{"key":"4286_CR38","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10286-025-01139-3","volume":"35","author":"G Prandin","year":"2025","unstructured":"Prandin G, Naccarato M, Furlanis G, Mancinelli L, Palacino F, Vincis E et al (2025) Role of beta-blocker therapy on the sympathetic effects in stroke heart syndrome. Clin Auton Res 35:759\u2013765","journal-title":"Clin Auton Res"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-026-04286-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-026-04286-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-026-04286-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:32:37Z","timestamp":1777091557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-026-04286-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4286"],"URL":"https:\/\/doi.org\/10.1007\/s10143-026-04286-x","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the UTHealth Institutional Review Board (IRB# HSC-MH-23\u20130749) on August 22, 2024. All procedures followed ethical standards and complied with the Declaration of Helsinki. The need for informed consent was waived due to the use of de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"379"}}